Jamaica scientist launches medical marijuana firm (Update)

by David Mcfadden

A prominent Jamaican scientist and entrepreneur is launching a company that aims to capitalize on medical marijuana, a growing global industry that he asserted Wednesday could be a boon for the island's chronically limping economy.

Henry Lowe, a researcher who specializes in medicinal chemistry and the chairman of an institute that develops therapeutic and cosmetic products from various plants in Jamaica, is calling his new venture Medicanja. It will focus on isolating medicinal compounds in the cannabis plant, known locally as "ganja," and Lowe said the research will not violate any local laws or international conventions.

Lowe said Jamaica could become a powerhouse in the nascent medical marijuana industry, health tourism and the development of innovative pot-derived items. Local scientists already have a history of creating marijuana-derived products, such as "Canasol," which helps relieve pressure in the eyes of glaucoma patients.

"This is a big opportunity for us," Lowe said in a phone interview.

Marijuana is pervasive on the Caribbean island despite being prohibited since 1913. It's long been used as a medicinal herb by Jamaican families and as a spiritual sacrament by Rastafarians. In 2001, a government-appointed commission said pot was "culturally entrenched" and recommended decriminalization, but the effort stalled.

Advocates for pot say it's time for Jamaica to give its moribund economy a boost by embracing cannabis-related ventures. With a growing number of U.S. states changing their marijuana laws, and voters in Washington and Colorado legalizing marijuana, the activists say Jamaica should decriminalize pot and stop worrying that might anger the U.S. The island has long been the Caribbean's biggest pot exporter to the U.S.

Influential politicians are increasingly taking up the idea. Health Minister Fenton Ferguson said last week that he is "fully on board" with medical marijuana, and the justice minister has said the Cabinet should be asked to consider changes to pot laws before the end of the year.

Some church leaders and lawmakers oppose decriminalization of even small amounts of marijuana, arguing the negative effects of the drug outweigh any benefits, especially for young people. But many of them say they have no problem with medical marijuana research.

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

US governors seek federal marijuana clearance

Dec 01, 2011

A pair of US governors have filed a petition asking the US federal government to allow wider use of medical marijuana by authorizing doctors to prescribe it and pharmacies to provide it.

Puerto Rico to debate medical use of marijuana

Sep 06, 2013

Legislators in Puerto Rico are preparing to debate a bill that would allow people to use marijuana for medicinal purposes in this conservative U.S. territory, officials said Thursday.

Recommended for you

Determine patient preferences by means of conjoint analysis

Jul 29, 2014

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues ...

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

User comments